Comparison of 2 Mattresses for the Prevention of Bedsores by Measuring Skin Pressure in the Sacral Area

NCT ID: NCT02735135

Last Updated: 2019-04-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-31

Study Completion Date

2019-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to compare the AIRSOFT DUO and the SENTRY 1200 constant pressure mattresses in terms of peak skin pressures measured at the sacral area.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The secondary objectives of the study are to compare the two devices in terms of:

A. body contact surface area. B. peak pressure at the heel area (combining right and left heels) C. occurrence of pressure ulcers anywhere on the body for 1 month D. patient comfort rated at 1 month (visual analog scale varying from 0-10) E. noise (Likert Scale). F. sleep quality (visual analog scale varying from 0-10).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pressure Ulcer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Airsoft Duo First

Patients randomized to this arm will be placed on an AIRSOFT DUO mattress for day 0. They will then be switched to a SENTRY 1200 mattress until the end of month 1.

Intervention: AIRSOFT DUO for 1 day Intervention: SENTRY 1200 for 1 month

Group Type EXPERIMENTAL

AIRSOFT DUO for 1 day

Intervention Type DEVICE

The patient is placed on an AIRSOFT DUO mattress for 1 day.

SENTRY 1200 for 1 month

Intervention Type DEVICE

The patient is placed on a SENTRY 1200 mattress for 1 month.

SENTRY 1200 First

Patients randomized to this arm will be placed on a SENTRY 1200 mattress for day 0. They will then be switched to an AIRSOFT DUO mattress until the end of month 1.

Intervention: SENTRY 1200 for 1 day Intervention: AIRSOFT DUO for 1 month

Group Type EXPERIMENTAL

SENTRY 1200 for 1 day

Intervention Type DEVICE

The patient is placed on a SENTRY 1200 mattress for 1 day.

AIRSOFT DUO for 1 month

Intervention Type DEVICE

The patient is placed on an AIRSOFT DUO mattress for 1 month.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AIRSOFT DUO for 1 day

The patient is placed on an AIRSOFT DUO mattress for 1 day.

Intervention Type DEVICE

SENTRY 1200 for 1 month

The patient is placed on a SENTRY 1200 mattress for 1 month.

Intervention Type DEVICE

SENTRY 1200 for 1 day

The patient is placed on a SENTRY 1200 mattress for 1 day.

Intervention Type DEVICE

AIRSOFT DUO for 1 month

The patient is placed on an AIRSOFT DUO mattress for 1 month.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patient must have given his/her informed and signed consent
* The patient must be insured or beneficiary of a health insurance plan
* The patient spends more than 12 hours in bed and verticalisation is possible
* The patient has a stable medical condition (no complication in the last 10 days) and no visible pressure ulcers
* The patient is at risk for pressure ulcers as assessed by a score ≤ 15 on the Braden Scale
* The patient weighs less than 120 kg

Exclusion Criteria

* The patient is in an exclusion period determined by a previous study
* The patient is under judicial protection, under tutorship or curatorship
* The patient refuses to sign the consent
* It is impossible to correctly inform the patient
* The subject has a contra-indication for a strictly supine position
* The patient has a knee flexion deformity \> 10 °
* The patient is in a state of agitation or refuses to cooperate
* The patient's weight is greater than 120 Kg
* The length of stay is less than one month
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Annie Bauer Confort

UNKNOWN

Sponsor Role collaborator

Centre Hospitalier Universitaire de Nīmes

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emilie Viollet, MD

Role: STUDY_DIRECTOR

Centre Hospitalier Universitaire de Nîmes

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CH de Beziers

Béziers, , France

Site Status

Clinique de Soins de suite et réadaptation Saint Basile

Mougins, , France

Site Status

CHRU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016-A00188-43

Identifier Type: OTHER

Identifier Source: secondary_id

LOCAL/2016/CEDMH-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.